- Investing Ideas
- /
- Biotech Breakthroughs
Biotech Breakthroughs
UPDATED May 29, 2024
Companys with strong funding and high growth potential
77 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
IDD | €2.58 | -3.7% | -4.4% | €207.0m | €6.37 | PS3.4x | E32.8% | n/a | Pharmaceuticals & Biotech | ||
41X | US$6.29 | -13.4% | 108.1% | US$1.5b | US$13.15 | PS9.7x | E60.7% | n/a | Pharmaceuticals & Biotech | ||
IMU | US$28.74 | 6.8% | 615.5% | US$8.4b | US$26.83 | PS29.1x | E45.9% | n/a | Pharmaceuticals & Biotech | ||
7UX | kr0.021 | 8.4% | -65.1% | kr61.6m | n/a | PS10.4x | E52.1% | n/a | Pharmaceuticals & Biotech | ||
IDDA | €2.46 | -6.1% | -6.1% | €207.0m | €6.07 | PS3.4x | E32.8% | n/a | Pharmaceuticals & Biotech | ||
9LB | US$38.60 | 6.6% | -35.1% | US$7.7b | US$76.17 | PS22.4x | E63.3% | n/a | Pharmaceuticals & Biotech | ||
B9A | kr20.02 | 5.0% | -28.3% | kr19.5b | kr33.37 | PS77.3x | E50.5% | 0% | Pharmaceuticals & Biotech | ||
CJH | HK$2.62 | 0% | -23.5% | HK$9.0b | HK$3.28 | PS13.7x | E124.6% | 0% | Pharmaceuticals & Biotech | ||
0QF | US$135.12 | -8.2% | 13.8% | US$58.7b | US$126.53 | PS11x | E68.8% | n/a | Pharmaceuticals & Biotech | ||
BIX0 | kr2.86 | 13.0% | 53.1% | kr2.1b | kr7.49 | PS34.1x | E89.0% | n/a | Pharmaceuticals & Biotech | ||
1RV | US$32.60 | -5.2% | 114.5% | US$2.2b | US$52.68 | PS23.5x | E65.6% | n/a | Pharmaceuticals & Biotech | ||
DR6 | US$13.81 | -5.2% | -36.7% | US$2.4b | US$25.65 | PS3x | E41.0% | n/a | Pharmaceuticals & Biotech | ||
328 | US$4.64 | -9.9% | -25.2% | US$321.5m | US$19.67 | PS28.3x | E56.1% | n/a | Pharmaceuticals & Biotech | ||
08D | US$22.40 | -6.7% | -8.2% | US$1.1b | US$44.41 | PS5.1x | E71.2% | n/a | Pharmaceuticals & Biotech | ||
NB11 | US$3.81 | 0% | -36.9% | US$541.2m | US$10.15 | PS1150.5x | E76.0% | n/a | Pharmaceuticals & Biotech | ||
2CX | US$51.89 | -0.9% | 79.0% | US$3.7b | US$51.90 | PS100.3x | E69.1% | n/a | Pharmaceuticals & Biotech | ||
O2T | US$36.00 | -0.6% | 226.4% | US$5.5b | US$36.05 | PB11.6x | E59.0% | n/a | Pharmaceuticals & Biotech | ||
1AEA | €332.00 | 0% | -8.3% | €20.9b | €412.83 | PS15.5x | E60.1% | n/a | Pharmaceuticals & Biotech | ||
I5X | US$1.22 | -2.2% | 8.0% | US$328.1m | US$8.56 | PS60.3x | E58.1% | n/a | Pharmaceuticals & Biotech | ||
8JD | €3.88 | -5.7% | -25.2% | €61.5m | €10.00 | PS9x | E87.5% | n/a | Pharmaceuticals & Biotech | ||
ZVAA | €2.52 | -6.0% | 48.2% | €239.4m | n/a | PS21.3x | E54.9% | n/a | Pharmaceuticals & Biotech | ||
1ZLB | US$1.60 | -6.4% | -48.4% | US$1.8b | US$4.58 | PS6.1x | E66.5% | n/a | Pharmaceuticals & Biotech | ||
XUP | €3.42 | 0% | n/a | €234.4m | €6.79 | PS6.8x | E54.7% | n/a | Pharmaceuticals & Biotech | ||
SGT | US$208.60 | 3.4% | 74.0% | US$43.2b | US$208.75 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech |